$CSCIF Income Statement | Understand Stock

$CSCIF

$5.16 -$0.34 (6.18%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
License fees
Development services
Product sales
Royalties
Supply chain revenue
Revenues
Cost of sales
Gross profit
Research and development
Selling expenses
Impairment of intangible assets (note 10)
Selling, general and administrative
Impairment of property and equipment (note 11)
Impairment of intangible assets (note 12)
Impairment of property and equipment (note 12)
Write-down of inventory (note 9)
Impairment of intangible assets (note 13)
Impairment of goodwill (note 11)
Impairment of other assets (note 7)
Total expenses
Loss from operations
Foreign exchange gain (loss)
Gain on sale of intangible asset (note 10)
Finance costs
Interest income
Net other costs
Other income
Change in fair value of warrant and DSU liabilities
Loss before income taxes
Income tax recovery (expense) (note 22)
Net loss
Other comprehensive loss:
Items that may be reclassified subsequently to profit or loss:
Foreign currency translation adjustments
Items that will not be reclassified to profit or loss:
Actuarial gain (loss) on defined benefit plans (note 16)
Comprehensive loss
Loss per share - Basic
Weighted average number of shares outstanding (basic and diluted)
Diluted
Loss per share - Diluted

Comments